https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51574 Wed 28 Feb 2024 15:29:53 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49615 Wed 14 Jun 2023 18:25:34 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19799 Wed 11 Apr 2018 15:56:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42916 Wed 07 Sep 2022 10:15:26 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42967 Wed 07 Feb 2024 16:43:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41418 Wed 03 Aug 2022 11:59:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41960 Tue 30 Apr 2024 08:49:39 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54492 Tue 27 Feb 2024 15:12:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50428 Tue 25 Jul 2023 18:54:37 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48576 Tue 21 Mar 2023 17:22:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37699 Tue 16 Mar 2021 17:44:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44236 Tue 11 Oct 2022 11:46:45 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35825 Tue 10 Dec 2019 11:47:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51428 Tue 05 Sep 2023 17:46:50 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45042 Thu 27 Oct 2022 13:54:01 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42064 Staphylococcus aureus bacteremia, Clostridium difficile infection, and vancomycin-resistant enterococci infections prevented in the intervention phase based on estimated reductions in the relative risk of infection. Changes to costs were defined as the cost of implementing the bundle minus cost savings from fewer infections. Health benefits gained from fewer infections were measured in quality-adjusted life-years (QALYs). Cost-effectiveness was evaluated using the incremental cost-effectiveness ratio and net monetary benefit of adopting the cleaning bundle over existing hospital cleaning practices. Results: Implementing the cleaning bundle cost $349 000 Australian dollars (AUD) and generated AUD$147 500 in cost savings. Infections prevented under the cleaning bundle returned a net monetary benefit of AUD$1.02 million and an incremental cost-effectiveness ratio of $4684 per QALY gained. There was an 86% chance that the bundle was cost-effective compared with existing hospital cleaning practices. Conclusions: A bundled, evidence-based approach to improving hospital cleaning is a cost-effective intervention for reducing the incidence of HAIs.]]> Thu 18 Aug 2022 11:06:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55116 Thu 11 Apr 2024 08:20:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42349 Thu 04 Apr 2024 11:57:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42697 Thu 01 Sep 2022 09:44:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42693 Thu 01 Sep 2022 09:27:28 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29250 Sat 24 Mar 2018 07:36:46 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39038 Mon 29 Jan 2024 17:52:28 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40674 Mon 18 Jul 2022 08:53:19 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40362 Mon 11 Jul 2022 14:21:57 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40996 Mon 08 Aug 2022 14:43:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51382 Mon 04 Sep 2023 09:56:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40007 Burkholderia cepacia healthcare-associated infections (HAIs). Design: Integrative review. Methods: A review of all outbreaks of Burkholderia cepacia HAIs published in the peer-reviewed literature between January 1970 and October 2019 was conducted to identify the global burden, associated point sources, and successful prevention and control measures using the Guidelines for Outbreak Reports and Intervention Studies of Nosocomial Infections (ORION). Results: In total, we reviewed 125 documented outbreaks of Burkholderia cepacia–related HAIs worldwide. The reported B. cepacia HAIs for this period involved 3,287 patients. The point sources were identified in most outbreaks of B. cepacia HAIs (n = 93; 74.4%); they included medication vials, disinfectants, and antiseptics. Moreover, 95 of the outbreak reports (76%) described effective prevention and control measures, but only 33 reports indicated the use of a combination of environment-, patient- and staff-related measures. None of the outbreak reports used the ORION guidelines. Conclusions: Outbreaks of Burkholderia cepacia HAIs are an ongoing challenge. They are often associated with immunocompromised patients who acquire the infection from exposure to contaminated medications, products, and equipment. These outbreaks are not infrequent, and a range of infection prevention and control measures have been effective in arresting spread. The use of ORION guidelines for outbreak reporting would improve the quality of information and data to generate evidence for translation into practice.]]> Fri 15 Jul 2022 10:11:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37048 Fri 07 Aug 2020 15:02:13 AEST ]]>